Clinical Trial Update: Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing zimberelimab plus domvanalimab with chemotherapy versus pembrolizumab with chemotherapy in patients with untreated metastatic non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Domvanalimab (domvanalimab)
• KEYTRUDA (PEMBROLIZUMAB)
• Zimberelimab (zimberelimab)

Snippet

Sponsor: Gilead Sciences | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING